These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18670668)

  • 1. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.
    Brinkhof MW; Dabis F; Myer L; Bangsberg DR; Boulle A; Nash D; Schechter M; Laurent C; Keiser O; May M; Sprinz E; Egger M; Anglaret X;
    Bull World Health Organ; 2008 Jul; 86(7):559-67. PubMed ID: 18670668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.
    Cornell M; Myer L; Kaplan R; Bekker LG; Wood R
    Trop Med Int Health; 2009 Jul; 14(7):722-31. PubMed ID: 19413745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
    Braitstein P; Brinkhof MW; Dabis F; Schechter M; Boulle A; Miotti P; Wood R; Laurent C; Sprinz E; Seyler C; Bangsberg DR; Balestre E; Sterne JA; May M; Egger M; ;
    Lancet; 2006 Mar; 367(9513):817-24. PubMed ID: 16530575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
    Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M;
    AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
    ; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
    AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
    Peltzer K; Ramlagan S; Khan MS; Gaede B
    SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.
    ; Keiser O; Anastos K; Schechter M; Balestre E; Myer L; Boulle A; Bangsberg D; Touré H; Braitstein P; Sprinz E; Nash D; Hosseinipour M; Dabis F; May M; Brinkhof MW; Egger M
    Trop Med Int Health; 2008 Jul; 13(7):870-9. PubMed ID: 18373510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.
    Ekouevi DK; Balestre E; Ba-Gomis FO; Eholie SP; Maiga M; Amani-Bosse C; Minga A; Messou E; Sow PS; Lewden C; Traoré HA; Bissagnene E; Dabis F;
    Trop Med Int Health; 2010 Jun; 15 Suppl 1(Suppl 1):34-42. PubMed ID: 20586958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
    Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.
    Forster M; Bailey C; Brinkhof MW; Graber C; Boulle A; Spohr M; Balestre E; May M; Keiser O; Jahn A; Egger M;
    Bull World Health Organ; 2008 Dec; 86(12):939-47. PubMed ID: 19142294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
    Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
    Tuboi SH; Brinkhof MW; Egger M; Stone RA; Braitstein P; Nash D; Sprinz E; Dabis F; Harrison LH; Schechter M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):52-9. PubMed ID: 17460471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    ; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
    Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis.
    Gupta A; Nadkarni G; Yang WT; Chandrasekhar A; Gupte N; Bisson GP; Hosseinipour M; Gummadi N
    PLoS One; 2011; 6(12):e28691. PubMed ID: 22220193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.